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Abstract. Seven tetraoxygenated xanthones, namely fuscaxanthone A, 7-O-methylgarcinone E, 
cowagarcinone A, cowaxanthone, rubraxanthone, cowanin and cowanol, were isolated from the 
dichloromethane extract of the latex of Garcinia cowa Roxb. ex Choisy. Their structures were 
elucidated on the basis of 1D, 2D NMR spectroscopic data and compared with reported data. 
This is the first time the chemical constituents of Garcinia cowa Roxb. ex Choisy have been 
investigated in Vietnam. 
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1. INTRODUCTION 
Garcinia cowa Roxb. ex Choisy (G. cowa), Clusiaceae family is widely distributed in 
Vietnam. The root and barks of G. cowa have been used in traditional medicine for treatment of 
fever or as antiseptic agent [1]. The fruits and young leaves of the tree are edible and are 
consumed popularly in Southeast Asian countries. Phytochemical studies and pharmacological 
activities of G. cowa from Thailand were reported recently [2 - 6]. According to previous 
reports, main chemical constituents of G. cowa are xanthones which were demonstrated 
interesting bioactivities such as antimalarial [2], antimicrobial [3, 5, 7], anti-inflammatory [4, 8], 
antioxidant [3, 4, 9], antibacterial [5, 10, 11], antitumor-promoting activity [12] and cytotoxic 
activities [13 - 15]. 
 As part of our research on this species growing in Vietnam, we report herein the isolation 
and structural elucidation of seven tetraoxygenated xanthones (1-7), those are fuscaxanthone A 
(1), 7-O-methylgarcinone E (2), cowagarcinone A (3), cowaxanthone (4), rubraxanthone (5), 
cowanin (6), and cowanol (7) from the dichloromethane (DCM) extract of latex of G. cowa 
collected in Phu Quoc island. 
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2. MATERIALS AND METHODS 
2.1. General 
NMR spectra were recorded on a Bruker Advance 500 spectrometer at 500 and 125 MHz 
for 
1
H and 
13
C, respectively, at Institute of Chemistry - Vietnam Academy of Science and 
Technology. Chemical shifts are shown in δ (ppm) in CDCl3 with tetramethylsilane (TMS) as an 
internal reference. Melting points were measured on Buchi B545 apparatus (no correction). 
Column chromatography (CC) were carried out on silica gel 60 (Merck, 5-40 μm), silica gel 100 
(Merck, 63-200 μm), and/or sephadex LH-20 (GE Healthcare). Visualization of thin layer 
chromatography (TLC) plates was performed using UV light (254 and 365 nm), staining with 
H2SO4 10 % solution. Commercial solvents were purified and dried, when necessary, by 
standard methods just prior to use. 
2.2. Plant materials  
The latex of G. cowa was collected in Phu Quoc island - Kien Giang province, in 
December 2015. The plant materials were identified by Dr. Nguyen Quoc Binh, Vietnam 
National Museum of Nature. The herbarium specimen has been deposited at Institute of Natural 
Products Chemistry - Vietnam Academy of Science and Technology with the plant specimen 
number GC2015128.  
2.2. Extraction and isolation 
The latex of G. cowa (3.0 kg) existing in a form of a brown solid, was crushed into small 
pieces and then was dried in the oven at the temperature of 45 
o
C in three days to achieve 2.8 kg 
dried latex. The dried latex was extracted with methanol (MeOH) (3 L × 3) at room temperature 
using conventional ultrasound-assisted technique. The solvent was evaporated under reduced 
pressure to give a dark brown residue (500.0 g). The residue was further extracted with DCM 
(500 mL × 3) to yield DCM extract (96.7 g). The left residue was then extracted with 
ethylacetate (EtOAc) (500 mL × 3) to afford EtOAc extract (145.1 g). 
The crude DCM extract was subjected to column chromatography over silica gel, eluted 
with DCM-MeOH in a polarity gradient manner (v/v, 100:0 to 0:100) to afford five fractions 
(Frs. GCN1–GCN5). Fraction GCN1 (22.4 g) was fractionated by employing CC with hexane-
EtOAc (v/v, 100:0 to 0:100) as an eluent to give ten subfractions GCN1.1-GCN1.10. 
Subfraction GCN1.4 (6.4 g) was chromatographed over silica gel, eluting with 50 % DCM-
hexane to afford five subfractions GCN1.4.1-GCN1.4.5. Further chromatography of subfraction 
GCN1.4.1 (0.8 g) over silica gel using hexane-acetone (v/v, 10:1) as the mobile phase to yield 
compound 1 as bright yellow oil (GCN141, 0.04 g). Crystallization of subfraction GCN1.4.2 
(1.83 g) in hexane-DCM (v/v, 1:1) provided compound 2 as pale yellow needles (GCN142, 0.23 
g). Subfraction GCN1.4.4 (0.71 g) was isolated by CC using eluent of 10 % acetone in hexane to 
give compound 3 which was crystalized in DCM to appear as pale yellow needles (GCN144, 
0.12 g). 
Subfraction GCN1.6 (3.5 g) was separated by repeated CC with DCM-hexane (v/v, 1:1) to 
yield compounds 6 (GCN162, 1.43 g) as a pale yellow solid.  
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Compound 4 (GCN182, 0.26 g), as a yellow solid, was obtained from subfraction GCN1.8 
(3.12 g) by repeated purification on sephadex LH-20 chromatography with eluent of 5 % DCM-
MeOH. 
 Fraction GCN2 (37.5 g) was fractionated by CC with a gradient of hexane-EtOAc (v/v, 
100:0 to 0:100) to afford eleven subfractions GCN2.1-GCN2.11. Subfraction GCN2.2 (1.76 g) 
was further purified by chromatography over silica gel with eluent of hexane-ethylacetate (v/v, 
16:1) to give compound 5 (GCN228, 0.02 g) as pale yellow solid. Subfraction GCN2.6 (2.2 g) 
was separated by Sephadex LH-20 chromatography with 100 % MeOH to give four 
subfractions. Compound 7 (GCN262, 0.85 g) was obtained from the second subfraction by 
crystallization in DCM to appear as yellow needles. 
Fuscaxanthone A (1): Bright yellow oil. 
1
H-NMR (500 MHz, CDCl3)  (ppm): 13.72 (s, 
OH-1), 6.86 (1H, s, H-5), 6.75 (1H, d, J = 10.0 Hz, H-10), 6.35 (1H, s, OH-6), 6.27 (1H, s, H-4), 
3.83 (3H, s, OCH3-7), 5.59 (1H, d, J = 10.0 Hz, H-11), 5.29 (1H, t, J = 5.5 Hz, H-2'), 5.05 (1H, 
br t, H-6'), 4.12 (2H, d, J = 6.0 Hz, H-1'), 2.08 (2H, m, H-4', H-5'), 2.04 (2H, m, H-4', H-5'), 1.85 
(3H, s, H-10'), 1.63 (3H, s, H-8'), 1.57 (3H, s, H-9'), 1.49 (6H, s, H-13,14). 
13
C-NMR (125 MHz, 
CDCl3)  (ppm): 181.9 (C-9), 159.8 (C-3), 157.9 (C-1), 156.3 (C-4a), 155.7 (C-5a), 154.5 (C-6), 
142.7 (C-7), 137.1 (C-8), 135.6 (C-3'), 131.3 (C-7’), 127.1 (C-11), 124.3 (C-6'), 124.3 (C-2'), 
115.7 (C-10), 112.3 (C-8a), 104.5 (C-2), 103.8 (C-9a), 101.6 (C-5), 94.1 (C-4), 77.9 (C-12), 62.1 
(7-OMe), 39.7 (C-4'), 28.3 (C-13, 14), 26.8 (C-1’), 26.5 (C-5'), 25.6 (C-8'), 17.7 (C-9'), 16.5 (C-
10'). 
7-O-methylgarcinone E (2): Pale yellow needles, m.p. 222-223
o
C. 
1
H-NMR (500 MHz, 
CDCl3) (ppm): 13.84 (1H, s, OH-1), 6.39 (1H, s, OH-6), 6.33 (1H, s, H-4), 6.10 (1H, s, OH-3), 
5.27 (1H, m, H-2'''), 5.27 (1H, m, H-2'), 5.25 (1H, m, H-2''), 4.07 (2H, d, J =  7.0 Hz, H- 1''), 
3.80 (3H, s, OCH3-7), 3.56 (2H, d, J = 7.0 Hz, H-1'''), 3.46 (2H, d, J = 7.0 Hz, H-l'), 1.87 (3H, s, 
H-4'''), 1.85(3H, s, H-4'), 1.82 (3H, s, H-4''), 1.77 (3H, s, H-5'), 1.69 (6H, s, H-5'', 5'''). 
13
C-NMR 
(125 MHz, CDCl3)  (ppm): 182.5 (C-9), 161.5 (C-3), 160.6 (C-1), 155.1 (C-4a), 153.6 (C-5a), 
152.3 (C-6), 142.3 (C-7), 131.8 (C-8), 135.8 (C-3'), 133.9 (C-3''), 132.7 (C-3'''), 123.5 (C-2''), 
121.5 (C-2'), 121.1 (C-2'''), 114.0 (C-5), 112.0 (C-8a), 108.3 (C-2), 103.6 (C-9a), 93.2 (C-4), 
62.0 (7-OMe), 26.4 (C-1''), 25.8 (C-5', 5'', 5'''), 22.6 (C-1'''), 21.5 (C-1'), 18.2 (C-4''), 18.0 (C-4'''), 
17.9 (C-4'). 
Cowagarcinone A (3): Pale yellow needles, m.p. 258-259
o
C. 
1
H-NMR (500 MHz, CDCl3) 
 (ppm): 13.85 (1H, s, OH-1), 6.41 (s, OH-6), 6.33 (1H, s, H-4), 6.13 (1H, s, OH-3), 5.31 (1H, 
m, H-2'), 5.28 (1H, m, H-2'''), 5.26 (1H, m, H-2''), 5.03 (1H, br t, J = 6.5Hz, H-6''), 4.07 (2H, d, J 
= 6.0 Hz, H-1''), 3.80 (3H, s, OCH3-7), 3.58 (2H, d, J = 7.5 Hz, H-1'''), 3.46 (2H, d, J = 7.5 Hz, 
H-1'), 2.01 (2H, m, H-5''), 1.99 (2H, m, H-4''), 1.88 (3H, s, H-4'''), 1.85 (3H, s, H-4'), 1.82 (3H, s, 
H-10''), 1.77 (3H, s, H-5'), 1.69 (3H, s, H-5'''), 1.60 (3H, s, H-8''), 1.55 (3H, s, H-9''). 
13
C-NMR 
(125 MHz, CDCl3)  (ppm): 182.3 (C-9), 161.6 (C-3), 160.5 (C-1), 155.1 (C-4a), 153.8 (C-5a), 
152.5 (C-6), 142.4 (C-7), 135.8 (C-3'), 135.6 (C-3''), 133.8 (C-8), 132.9 (C-3'''), 131.3 (C-7''), 
124.4 (C-6''), 123.4 (C-2''), 121.5 (C-2'), 121.3 (C-2'''), 113.7 (C-5), 112.0 (C-8a), 108.4 (C-2), 
103.7 (C-9a), 93.3 (C-4), 62.1 (7-OMe), 39.5 (C-4''), 26.5 (C-1''), 26.3 (C-5''), 25.8 (C-5'), 25.6 
(C-5'''), 25.6 (C-9''), 22.5 (C-1'''), 22.5 (C-1'), 18.0 (C-4'''), 17.9 (C-4'), 17.8 (C-10''), 16.7 (C-8''). 
Cowaxanthone (4): Yellow solid, m.p. 196-197
o
C. 
1
H-NMR (500 MHz, CDCl3)  (ppm): 
7.53 (1H, s, H-8), 6.82 (1H, s, H-5), 6.31 (1H, s, H-4), 5.25 (2H, dd, J = 6.5 Hz, 7.0Hz, H-2'), 
5.03 (2H, m, H-6'), 3.94 (3H, s, OCH3-7), 3.36 (2H, d, J = 7.5 Hz, H-1'), 2.04 (2H, m, H-5'), 
1.96 (2H, m, H-4'), 1.77 (3H, s, H-10'), 1.60 (3H, s, H-9'), 1.53 (3H, s, H-8'). 
13
C-NMR (125 
MHz, CDCl3)  (ppm): 179.9 (C-9), 162.2 (C-3), 160.0 (C-1), 156.0 (C-4a), 152.9 (C-5a), 152.6 
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(C-6), 144.8 (C-7), 136.9 (C-3'), 131.4 (C-7'), 124.2 (C-6'), 121.8 (C-2'), 113.3 (C-8a), 110.0 (C-
2), 105.0 (C-5), 102.8 (C-9a), 102.6 (C-8), 93.6 (C-4), 56.4 (C7-OMe), 39.7 (C-4'), 26.6 (C-5'), 
25.5 (C-9'), 21.3 (C-1'), 17.5 (C-9'), 16.1 (C-10'). 
Rubraxanthone (5): Pale yellow solid, m.p. 201-202
o
C. 
1
H-NMR (500 MHz, CDCl3)  
(ppm): 6.70 (1H, s, H-5), 6.19 (1H, d, J = 2.0 Hz, H-4), 6.12 (1H, d, J = 2.0 Hz, H-2), 5.18 (1H, 
m, H-2''), 4.97 (1H, m, H-6''), 4.03 (2H, d, J = 6.0 Hz, H-1''), 3.71 (3H, s, OCH3-7), 1.97 (2H, m, 
H-5''), 1.93 (2H, m, H-4''), 1.76 (3H, s, H-10''), 1.53 (3H, s, H-9''), 1.48 (3H, s, H-8''). 
13
C-NMR 
(125 MHz, CDCl3)  (ppm): 181.9 (C-9), 164.0 (C-3), 163.1 (C-1), 157.1 (C-4a), 155.8 (C-5a), 
155.6 (C-6), 143.3 (C-7), 137.4 (C-8), 135.2 (C-3''), 131.2 (C-7''), 124.3 (C-6''), 123.4 (C-2''), 
111.6 (C-8a), 101.8 (C-5), 103.2 (C-9a), 97.8 (C-2), 93.4 (C-4), 61.1 (C7-OMe), 39.7 (C-4''), 
26.5 (C-5''), 26.2 (C-1''), 25.5 (C-9''), 16.3 (C-10''). 
Cowanin (6): Pale yellow solid, m.p. 135-137
o
C. 
1
H-NMR (500 MHz, CDCl3)  (ppm): 
13.79 (1H, s, OH-1), 6.83 (1H, s, H-5), 6.32 (1H, s, OH-6), 6.29 (1H, s, H-4), 6.14 (1H, s, OH-
3), 5.29 (1H, m, H-2'), 5.26 (2H, m, H-2''), 5.03 (2H, t, J = 7.0 Hz, H-6''), 4.10 (2H, d, J = 6.5 
Hz, H-1''), 3.80 (3H, s, OCH3-7), 3.46 (2H, d, J = 7.0 Hz, H-1'), 2.06 (2H, m, H-5''), 2.01 (2H, 
m, H-4''), 1.84 (3H, s, H-4'), 1.83 (3H, s, H-10''), 1.77 (3H, s, H-5'), 1.59 (3H, s, H-9''), 1.55 (3H, 
s, H-8''). 
13
C-NMR (125 MHz, CDCl3)  (ppm): 182.0 (C-9), 161.6 (C-3), 160.7 (C-1), 155.1 (C-
5a), 155.8 (C-6), 154.5 (C-4a), 142.6 (C-7), 137.1 (C-8), 135.8 (C-3'), 135.6 (C-3''), 131.3 (C-
7''), 124.3 (C-6''), 123.2 (C-2''), 121.5 (C-2'), 101.5 (C-5), 112.3 (C-8a), 108.4 (C-2), 103.7 (C-
9a), 93.3 (C-4), 62.1 (7-OMe), 39.7 (C-5''), 26.6 (C-4''), 26.5 (C-1''), 25.8 (C-5'), 25.6 (C-9''), 
21.5 (C-1'), 17.9 (C-4'), 17.7 (C-8''), 16.5 (C-10''). 
Cowanol (7): Yellow needles, m.p. 123-124
o
C. 
1
H-NMR (500 MHz, CDCl3)  (ppm): 
13.83 (1H, s, OH-1), 6.77 (1H, s, H-5), 6.26 (1H, s, H-4), 5.49 (1H, dt, J = 8.0 Hz, 1.5Hz, H-2’), 
5.25 (1H, dt, J = 6.0 Hz, 1.0 Hz, H-2''), 5.03 (1H, m, H-6''), 4.35 (2H, s, H-4'), 4.08 (2H, d, J = 
6.5 Hz, H-1''), 3.80 (3H, s, OCH3-7), 3.46 (2H, d, J = 7.0 Hz, H-1’), 2.04 (2H, m, H-5''), 1.99 
(2H, m, H-4''), 1.83 (3H, br s, H-10''), 1.79 (3H, s, H-5'), 1.60 (3H, d, J = 1.0 Hz, H-9''), 1.54 
(3H, s, H-8''). 
13
C-NMR (125 MHz, CDCl3)  (ppm): 181.9 (C-9), 161.6 (C-3), 160.8 (C-1), 
155.2 (C-4a), 155.8 (C-5a), 154.7 (C-6), 142.8 (C-7), 137.3 (C-8), 135.5 (C-3''), 133.5 (C-3’), 
131.2 (C-7''), 126.9 (C-2'), 124.4 (C-6''), 123.4 (C-2''), 112.3 (C-8a), 108.4 (C-2), 103.5 (C-9a), 
101.7 (C-5), 93.6 (C-4), 62.7 (C-4'), 61.9 (7-OMe), 39.7 (C-4''), 26.7 (C-5''), 26.5 (C-1''), 25.5 
(C-9''), 22.6 (C-5'), 21.5 (C-1'), 17.6 (C-8''), 16.5 (C-10''). 
3. RESULTS AND DISCUSSION 
Compounds 1-7 were isolated from the DCM extract of the latex of G. cowa using repeated 
column chromatography on silica gel and sephadex LH-20 eluted with appropriate solvent 
mixtures. These compounds showed strong UV apsorption band of xanthone chromophore at 
λmax = 254 nm. Their spectral database (
1
H, 
13
C-NMR) contain characteristic sp
2
 protons, 
aromatic carbons and a carbonyl group for a xanthonoid skeleton with 1-3 prenyl or geranyl side 
chains. The structures of the isolated compounds are shown in Figure 1. 
The 
1
H, 
13
C-NMR and HSQC spectra of compound 1 revealed 29 carbons including 5xCH3, 
1xOMe, 6xCH sp
2
, 3xCH2 and 14xCq (one C=O at C 181.9). Furthermore, the COSY and 
HMBC correlations showed the presence of a tetraoxygenated xanthonoid skeleton with a 
geranyl group (C1'-C10') and a dimethylpyran ring (C10-C14) with a double bond C-10 (C 
115.7, H 6.75)/ C-11 (C 127.1, H 5.59). Substituent positions were determined by C-H long-
range correlations in the HMBC spectrum: proton of methoxy group to C-7; protons H-1' of 
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geranyl group to C-7, -8 and protons H-10, -11 to C-2. Two singlets at H 6.27 and 6.86 were 
assigned to H-4 and H-5 by HMBC correlations of proton H-5 to C-6, -7 and the correlation of 
proton H-4 to C-3. By combination of all NMR spectral data and comparison with reported 
values [16], the structure of 1 was determined as fuscaxanthone A. 
Compounds 2-7 also contain a tetraoxygenated xanthonoid skeleton with similar signals in 
their 
1
H and 
13
C-NMR spectra (12 aromatic carbons and a carbonyl group). All these compounds 
contain three phenolic hydroxyl groups at position C-1, -3, -6 and one methoxy group at C-7 on 
the xanthone frame. NMR data of compound 2 demonstrated the presence of three prenyl groups 
including 6xCH3, 3xCH=, 3xCH2 and 3xCq sp
2
. The position of each prenyl group was 
determined by HMBC correlations between C-2, -3/H-4', -1'; C-7, -8/H-1'' and C-6/H-1'''. All the 
NMR data of 2 were identical to reported values [6] of 7-O-methylgarcinone E.  
The NMR spectrum of compound 3 exhibited 2xCH2, 1xCH3, 1xCH= and 1xCq sp
2
 more 
than compound 2. Analysing the structure of 3 in comparison with reported value [9], 3 was 
determined to be cowagarcinone A.  
Compound 4 or 5 contains only one geranyl group substituting on xanthonoid skeleton. The 
HMBC correlations of H-1' to C-1, -2, -3 in compound 4 and the correlation of H-1', -2' to C-8 in 
compound 5 proved that the geranyl group bonds to C-2 for 4 and to C-8 for 5. Therefore, the 
structure of 4 and 5 were elucidated as cowaxanthone [5] and rubraxanthone [17,18], 
respectively. 
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Figure 1. Structures of compound 1-7. 
The 
1
H and 
13
C-NMR spectrum of compound 6 exhibited the same resonance signals with 
those of compound 5 except for the replacement of aromatic proton H-2 by a prenyl group. The 
HMBC spectrum showed the correlation of H-1' to C-1, -2, -3 suggesting the appearance of one 
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prenyl group on the xanthone frame. In addition, all the NMR data of 6 were identical to those of 
reported values of cowanin [5]. 
The NMR spectral data and HMBC correlations of compound 7 were identical to those of 
cowanin (6) except for the absence of one methyl of the prenyl group and the appearance of an 
oxygenated methylenic group. The HMBC correlations of H-2’ to the oxygenated methylenic 
carbon C-4' and the correlation of H-4' to C-2', -3', -5' proved that the hydroxyl group bonds to 
C-4'. Thus, compound 7 was determined as cowanol [5].  
The antimalarial potential of 7-O-methylgarcinone E (2), cowaxanthone (4), cowanin (6) 
and cowanol (7) against Plasmodium falciparum was examined by Likhitwitayawuid K. et al. in 
1998. All of these four compounds exhibited moderate activity against Plasmodium 
falciparum with their IC50 values in the range of 1.50-3.00 µg/mL [2]. Evaluation of the 
antibacterial activity against Gram-positive bacteria: B. cereus TISTR 688, B. subtilis TISTR 
008 and M. luteus TISTR 884 of compound rubraxanthone (5) and cowanin (6) showed that they 
both exhibited good activity with MICs of 6 in the range of 4–8 μg/mL while 5, had better 
activity with MICs in the range of 1-2 μg/mL [11]. 
4. CONCLUSIONS 
The dichloromethane extract of the latex of Garcinia cowa Roxb. ex Choisy (Clusiaceae) 
collected from Phu Quoc island was separated by means of chromatography. Accordingly, seven 
tetraoxygenated xanthones were isolated and elucidated as fuscaxanthone A (1), 7-O-
methylgarcinone E (2), cowagarcinone A (3), cowaxanthone (4), rubraxanthone (5), cowanin (6) 
and cowanol (7). These compounds are first isolated and identified from Garcinia cowa Roxb. 
ex Choisy growing in Vietnam. 
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